| Dr Nabeel Syed Ali, MD | |
|
7601 Southcrest Pkwy, Southaven, MS 38671-4739 | |
| (662) 772-2980 | |
| (662) 772-2960 |
| Full Name | Dr Nabeel Syed Ali |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 9 Years |
| Location | 7601 Southcrest Pkwy, Southaven, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184079246 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Memorial Hospital Desoto | Southaven, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baptist Memorial Medical Group, Inc. | 5193610228 | 433 |
News Archive
Stimatix GI reported that the AOS-C1000(TM), a unique colostomy management device, met primary and secondary endpoints in pre-clinical in-vivo animal studies. The study was conducted under the direction of Dr. Ron Greenberg, Senior Surgeon, Department of Surgery, Sourasky Medical Center, Tel Aviv Israel. Primary endpoints of repeatable stoma sealing for continence control as well as secondary endpoints regarding tissue pathology and survival were met confirming the AOS-C1000(TM) as capable of enabling repeatable colostomy site (stoma) sealing for continence control.
The Associated Press: "In a defeat for the powerful drug lobby, a Senate panel approved legislation to prohibit drug companies from paying generic drug makers to delay bringing less costly products to market. … The measure would ban a 'pay-to-delay' practice — opposed by the [Federal Trade Commission] in a series of lawsuits brought since 2001 — in which brand-name drug companies and generic drug makers both profit. Brand-name drug makers get higher prices while the generic companies are paid to stay out of the market."
Magnetic resonance imaging scans taken pre- and post-neoadjuvant chemotherapy for International Retinoblastoma Staging System stage III retinoblastoma can indicate a patient's likely event-free and overall survival, indicate study results.
Genetically modified (GM) plants are to be used to grow vaccines for use in the worldwide fight against HIV, tuberculosis, diabetes and rabies thanks to a grant of 12 million euros from the EU's Sixth Framework Programme (FP6).
"Nobel peace prize winner Aung San Suu Kyi has accepted a new role with UNAIDS to advance efforts to eliminate stigma and discrimination against those affected by the epidemic," the U.N. News Centre reports.
› Verified 3 days ago
| Entity Name | Baptist Memorial Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306089206 PECOS PAC ID: 5193610228 Enrollment ID: O20101011000028 |
News Archive
Stimatix GI reported that the AOS-C1000(TM), a unique colostomy management device, met primary and secondary endpoints in pre-clinical in-vivo animal studies. The study was conducted under the direction of Dr. Ron Greenberg, Senior Surgeon, Department of Surgery, Sourasky Medical Center, Tel Aviv Israel. Primary endpoints of repeatable stoma sealing for continence control as well as secondary endpoints regarding tissue pathology and survival were met confirming the AOS-C1000(TM) as capable of enabling repeatable colostomy site (stoma) sealing for continence control.
The Associated Press: "In a defeat for the powerful drug lobby, a Senate panel approved legislation to prohibit drug companies from paying generic drug makers to delay bringing less costly products to market. … The measure would ban a 'pay-to-delay' practice — opposed by the [Federal Trade Commission] in a series of lawsuits brought since 2001 — in which brand-name drug companies and generic drug makers both profit. Brand-name drug makers get higher prices while the generic companies are paid to stay out of the market."
Magnetic resonance imaging scans taken pre- and post-neoadjuvant chemotherapy for International Retinoblastoma Staging System stage III retinoblastoma can indicate a patient's likely event-free and overall survival, indicate study results.
Genetically modified (GM) plants are to be used to grow vaccines for use in the worldwide fight against HIV, tuberculosis, diabetes and rabies thanks to a grant of 12 million euros from the EU's Sixth Framework Programme (FP6).
"Nobel peace prize winner Aung San Suu Kyi has accepted a new role with UNAIDS to advance efforts to eliminate stigma and discrimination against those affected by the epidemic," the U.N. News Centre reports.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nabeel Syed Ali, MD 965 Ridge Lake Blvd Ste 315, Memphis, TN 38120-9401 Ph: () - | Dr Nabeel Syed Ali, MD 7601 Southcrest Pkwy, Southaven, MS 38671-4739 Ph: (662) 772-2980 |
News Archive
Stimatix GI reported that the AOS-C1000(TM), a unique colostomy management device, met primary and secondary endpoints in pre-clinical in-vivo animal studies. The study was conducted under the direction of Dr. Ron Greenberg, Senior Surgeon, Department of Surgery, Sourasky Medical Center, Tel Aviv Israel. Primary endpoints of repeatable stoma sealing for continence control as well as secondary endpoints regarding tissue pathology and survival were met confirming the AOS-C1000(TM) as capable of enabling repeatable colostomy site (stoma) sealing for continence control.
The Associated Press: "In a defeat for the powerful drug lobby, a Senate panel approved legislation to prohibit drug companies from paying generic drug makers to delay bringing less costly products to market. … The measure would ban a 'pay-to-delay' practice — opposed by the [Federal Trade Commission] in a series of lawsuits brought since 2001 — in which brand-name drug companies and generic drug makers both profit. Brand-name drug makers get higher prices while the generic companies are paid to stay out of the market."
Magnetic resonance imaging scans taken pre- and post-neoadjuvant chemotherapy for International Retinoblastoma Staging System stage III retinoblastoma can indicate a patient's likely event-free and overall survival, indicate study results.
Genetically modified (GM) plants are to be used to grow vaccines for use in the worldwide fight against HIV, tuberculosis, diabetes and rabies thanks to a grant of 12 million euros from the EU's Sixth Framework Programme (FP6).
"Nobel peace prize winner Aung San Suu Kyi has accepted a new role with UNAIDS to advance efforts to eliminate stigma and discrimination against those affected by the epidemic," the U.N. News Centre reports.
› Verified 3 days ago
Saif M Tahsin, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7601 Southcrest Pkwy, Southaven, MS 38671 Phone: 662-772-2980 Fax: 662-772-2960 | |
Dr. Beth A Choby, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 7736 Airways Blvd, Southaven, MS 38671 Phone: 662-772-3700 Fax: 662-772-3719 | |
John Carl Biery Jr., D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7736 Airways Blvd, Southaven, MS 38671 Phone: 662-772-3700 Fax: 662-772-3719 | |
Dr. Gary Dwain Carr, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 6858 Swinnea Rd Bldg 7, Southaven, MS 38671 Phone: 662-510-8400 Fax: 662-510-8500 | |
Walter Earl Carnahan, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7900 Airways Blvd, Bldg A Suite 6, Southaven, MS 38671 Phone: 662-536-4646 Fax: 662-536-4443 | |
Jennifer B Warren, FNP-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3495 Cobblestone Blvd S, Southaven, MS 38672 Phone: 662-892-2885 Fax: 662-890-1551 |